Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,230.71
(
-0.16%
)
Brent Oil
100.66
(
0.00%
)
Bitcoin
77,984.05
(
0.47%
)
News Focus
News Focus
Post# of 257443
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122886
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 124087

Thursday, 07/28/2011 1:46:02 PM

Thursday, July 28, 2011 1:46:02 PM

Post# of 257443
Speaking of a Catch-22 on pricing…JNJ and Bayer have one with Xarelto. Do they price it sky high for the relatively short duration of VTE prevention following orthopedic surgery, or do they price it much lower to garner off-label (and eventually on-label) business at the expense of Pradaxa/Eliquis in AF? There’s a huge expanse between these two poles.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today